Evidence map›Paper›PMID 38612895›Full record

ArticleInternational journal of molecular sciences2024

MiR-21 Regulates Growth and Migration of Cervical Cancer Cells by RECK Signaling Pathway.

Seidy Y Aguilar-Martínez, Gabriela E Campos-Viguri, Selma E Medina-García, Ricardo J García-Flores, Jessica Deas, Claudia Gómez-Cerón, Abraham Pedroza-Torres, Elizabeth Bautista-Rodríguez, Gloria Fernández-Tilapa, Mauricio Rodríguez-Dorantes and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. MicroRNAs as Biomarkers of Cervical Cancers.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Seidy Y Aguilar-MartínezDirection of Chronic Infections and Cancer, Research Center in Infection Diseases, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.
Gabriela E Campos-ViguriDirection of Chronic Infections and Cancer, Research Center in Infection Diseases, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.ORCID 0000-0001-8674-3953
Selma E Medina-GarcíaDirection of Chronic Infections and Cancer, Research Center in Infection Diseases, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.
Ricardo J García-FloresDirection of Chronic Infections and Cancer, Research Center in Infection Diseases, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.
Jessica DeasDirection of Chronic Infections and Cancer, Research Center in Infection Diseases, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.
Claudia Gómez-CerónDepartment of Epidemiology of Cancer, Research Center Population Health, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.
Abraham Pedroza-TorresPrograma Investigadoras e Investigadores por México, Consejo Nacional de Humanidades, Ciencias y Tecnologías, México City 14080, Mexico.ORCID 0000-0001-7857-3464
Elizabeth Bautista-RodríguezClinical Chemistry, Faculty of Health Sciences, Universidad Autónoma de Tlaxcala, Zacatelco 90750, Mexico.ORCID 0000-0003-0410-0415
Gloria Fernández-TilapaClinical Research Laboratory, Faculty of Chemical Biological Sciences, Universidad Autónoma de Guerrero, Chilpancingo 39070, Mexico.ORCID 0000-0002-3737-2399
Mauricio Rodríguez-DorantesOncogenomics Laboratory, Instituto Nacional de Medicina Genómica, Tlalpan, México City 14610, Mexico.
Carlos Pérez-PlasenciaOncogenomics Laboratory, Instituto Nacional de Cancerología, México City 14080, Mexico.ORCID 0000-0002-8593-8211
Oscar Peralta-ZaragozaDirection of Chronic Infections and Cancer, Research Center in Infection Diseases, Instituto Nacional de Salud Pública, Cuernavaca 62100, Mexico.
Instituto Nacional de Salud Pública · MXAutonomous University of Tlaxcala · MXInstituto Nacional de Cancerología · MXNational Institute of Genomic Medicine · MXUniversidad Autónoma de Guerrero · MX

Funding

Consejo Nacional de Humanidades, Ciencias y Tecnologías CF-MG-20191007114743133-61531.
6 · The paper itself

Abstract

Expression of miR-21 has been found to be altered in almost all types of cancers, and it has been classified as an oncogenic microRNA. In addition, the expression of tumor suppressor gene RECK is associated with miR-21 overexpression in high-grade cervical lesions. In the present study, we analyze the role of miR-21 in RECK gene regulation in cervical cancer cells. To identify the downstream cellular target genes of upstream miR-21, we silenced endogenous miR-21 expression using siRNAs. We analyzed the expression of miR-21 and RECK, as well as functional effects on cell proliferation and migration. We found that in cervical cancer cells, there was an inverse correlation between miR-21 expression and RECK mRNA and protein expression. SiRNAs to miR-21 increased luciferase reporter activity in construct plasmids containing the RECK-3'-UTR microRNA response elements MRE21-1, MRE21-2, and MRE21-3. The role of miR-21 in cell proliferation was also analyzed, and cancer cells transfected with siRNAs exhibited a markedly reduced cell proliferation and migration. Our findings indicate that miR-21 post-transcriptionally down-regulates the expression of RECK to promote cell proliferation and cell migration inhibition in cervical cancer cell survival. Therefore, miR-21 and RECK may be potential therapeutic targets in gene therapy for cervical cancer.

Indexed as

MicroRNAsUterine Cervical NeoplasmsCell MovementCell ProliferationFemaleGPI-Linked ProteinsHumansPsychomotor AgitationRNA, Double-StrandedRNA, Small InterferingSignal TransductionGPI-Linked ProteinsMicroRNAsMIRN21 microRNA, humanRECK protein, humanRNA, Double-StrandedRNA, Small Interferingcervical cancerHPVmicroRNAsmiR-21RECKsiRNAs

Identifiers

PMID38612895
PMCPMC11012906
OpenAlexW4394567980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.